Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
07/2006
07/20/2006US20060160798 3-Cyclohexyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carboxylic acid methyl ester; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons
07/20/2006US20060160796 N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases
07/20/2006US20060160794 Such as [1-(3,5-bis-trifluoromethylbenzyl)-5-imidazol-1-yl-1H-[1,2,3]triazol-4-yl]-[5-(2-chlorophenyl)-3-hydroxymethyl-isoxazol-4-yl]-methanone; for treatment of depression, anxiety, irritable bowel syndrome, and emesis
07/20/2006US20060159882 Optical recording materials having high storage density
07/20/2006US20060159678 Modulators of cytokine mediated signaling pathways and integrin alphabeta3 receptor antagonists for combination therapy
07/20/2006CA2594871A1 Exo- and diastereo- selective syntheses of himbacine analogs
07/20/2006CA2594860A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity
07/20/2006CA2594569A1 Synthesis of sodium narcistatin and related compounds
07/20/2006CA2594384A1 Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
07/20/2006CA2593450A1 Indole derivatives for treating viral infections
07/20/2006CA2592611A1 2-(cyclic aminocarbonyl)indoline derivative and medicinal composition containing the same
07/20/2006CA2590664A1 Macrocyclic compounds and compositions useful as bace inhibitors
07/20/2006CA2493508A1 An improved process for the preparation of mycophenolate mofetil
07/19/2006EP1681287A1 Benzoxazole compounds, process for producing the same, and herbicides
07/19/2006EP1681286A1 Benzoxazole compounds, process for producing the same, and herbicides
07/19/2006EP1681058A2 Pharmacologically active cns compounds
07/19/2006EP1680417A1 1-'(e)-2-(phenyl)ethenyl-4-(arylalkoxy)-oxazole or -thiazole compounds as her-2 tyrosine kinases inhibitors and their use in the treatment of cancer
07/19/2006EP1680408A2 Ccr3 receptor antagonists
07/19/2006EP1680406A1 N-substituted benzene sulfonamides
07/19/2006EP1680401A2 Indolinone derivatives and their use in treating disease-states such as cancer
07/19/2006EP1680124A2 Bicyclic [3.1.0] derivatives as glycine transporter inhibitors
07/19/2006EP1680114A2 Triazole compounds and uses related thereto
07/19/2006EP1680113A2 Dopamine-, norepinephrine- and serotonin- transporter- selective heterocyclic compounds and their therapeutic applications
07/19/2006EP1680107A1 Substituted oxadiazolidinediones als pai-1 inhibitors
07/19/2006CN1805957A Azetidine compounds
07/19/2006CN1805951A Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase
07/19/2006CN1805950A Method for preparing fused oxazinones
07/19/2006CN1805943A Alpha substituted carboxylic acid as PPAR modulators
07/19/2006CN1805940A Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
07/19/2006CN1803821A Method for preparing azithromycin dihydrochloride
07/19/2006CN1803798A Method for producing fungicide compand
07/19/2006CN1803797A Inhibitors of dipeptidyl peptidase IV
07/19/2006CN1803795A Substituted piperidine compounds for use as h3 histamine receptor antagonists
07/19/2006CN1264839C Non-nucleoside reverse transcriptase inhibitors
07/19/2006CN1264825C Dihydro-benzo [b][1,4] diazepin-2-one derivative as mglur 2 antagonists II
07/18/2006USRE39197 diaryl sulfides, substituted with cinnamides, such as (2,4-Dichlorophenyl)[2-(E-((6-hydroxyhexylamino)carbonyl)ethenyl)phenyl]sulfide, used for treating inflammatory and immune diseases in mammals
07/18/2006US7078541 Antiinflammatory agents; antiischemic agents; central nervous system disorders; prevent tissue degradation
07/18/2006US7078536 Antiproliferative agents; for prevention of infections; for veterinary medicine, agriculture
07/18/2006US7078424 Central nervous system disorders; alopecia
07/18/2006US7078422 Activator for peroxisome proliferator-activated receptor
07/18/2006US7078421 Substituted phenylacetic acids
07/18/2006US7078419 Cytokine inhibitors
07/18/2006US7078418 e.g., 2,6-bis(1-aziridino-1-hydroxyiminomethyl)pyridine; treating colon, stomach, lung, breast and uterus cancer
07/18/2006US7078403 Antiviral agents
07/18/2006US7078401 "PGI2-preferring" (IP) receptors; p-(imidazolin-2-ylamino-optional alkyl)phenyl p'-substituted ethers or sulfides, e.g., 4,5-Dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxy-phenylsulfanyl)-phenyl]-amine, used to induce hyperalgesia
07/18/2006CA2356320C Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
07/18/2006CA2242425C Quinazoline derivatives as vegf inhibitors
07/13/2006WO2006074388A2 TRICYCLIC δ-OPIOID MODULATORS
07/13/2006WO2006073967A1 Piperidine derivatives as prodrugs of potassium channel inhibitors
07/13/2006WO2006073361A1 Novel pyridine compounds
07/13/2006WO2006073167A1 Pyrrolidine derivatives
07/13/2006WO2006072736A1 N- (heteroaryl) -1h-indole-2-carb0xamide derivatives and their use as vanilloid trpv1 receptor ligands
07/13/2006WO2006072350A1 Cyanoguanidine-substituted pyrazolines
07/13/2006WO2006042478A8 Small-molecule inhibitors of coronaviral main protease, their preparation and use
07/13/2006WO2006039718A3 Aryl nitrogen-containing bicyclic compounds and their use as kinase inhibitors
07/13/2006WO2006034093A3 3- (2-acylamino-1-hydroxyethyl)- morpholine derivatives and their use as bace inhibitors
07/13/2006WO2004065367A8 Viral polymerase inhibitors
07/13/2006US20060155123 Donor dye with absorption maxima at 250-450 nm wavelength; acceptor dye emitting light with maxima greater than 500 nm. in response to absorbing energy emitted by doner; especially with donor and acceptor dyes linked together
07/13/2006US20060154967 e.g. [2-methyl-5-trifluoromethyl-2H-1,2,3-triazole-4-carboxylic acid methyl ester; fungicide; against the phytopathogenic fungi: Fungi imperfecti (Botrytis, Pyricularia, Helminthosporium), Basidiomycetes (Rhizoctonia, Hemileia), Ascomycetes classes (Venturia, Erysiphe), Oomycetes classes (Phytophthora)
07/13/2006US20060154964 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
07/13/2006US20060154949 Arylindenopyridines and related therapeutic and prophylactic methods
07/13/2006US20060154942 Quinazolinone derivatives useful as anti-hyperalgesic agents
07/13/2006US20060154917 Substituted (heterocycloalkyl)methyl azole derivatives as c5a receptor modulators
07/13/2006US20060154916 Condensed azepines as vasopressin agonists
07/13/2006US20060154913 Drugs for treatment of respiratory syncytial virus and salt formation
07/13/2006US20060154899 Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma
07/13/2006US20060153784 Bis(o-allyloxy)anilinocarbonyl)-benzene or -naphthalene intermediates for preparing bis(benzoxazolyl)-benzene or -naphthalene sunscreens
07/13/2006CA2594418A1 N-(heteroaryl)-1h-indole-2-carb0xamide derivatives and their use as vanilloid trpv1 receptor ligands
07/13/2006CA2594347A1 Tricyclic d-opioid modulators
07/13/2006CA2594255A1 Novel pyridine compounds
07/13/2006CA2593098A1 Sulfonyl pyrrolidines, method for producing the same and their use as drugs
07/13/2006CA2590110A1 Kinase modulators and method of use
07/13/2006CA2587195A1 Cycloalkyl keto piperidine tachykinin receptor antagonists
07/12/2006EP1679313A2 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
07/12/2006EP1679310A1 Phenylene derivative having tetrazole ring or thiazolidinedione ring
07/12/2006EP1679308A1 Novel indazole derivative
07/12/2006EP1679073A1 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(imino-heterocyclyl)-phenyl-amide derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses
07/12/2006EP1678173A2 4-heterobicyclylamino-substituted quinazolines and analogues thereof as capsaicin-antagonists
07/12/2006EP1678170A1 Use of a compound of formula (i) as an inhibitor of aromatase for therapeutic purposes and compounds of formula (1) thereas
07/12/2006EP1678169A1 4-(pyrazol-3-ylamino)pyrimidine derivatives for use in the treatment of cancer
07/12/2006EP1678167A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
07/12/2006EP1678147A1 Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
07/12/2006EP1678145A2 Benzimidazoles useful as modulators of ion channels
07/12/2006EP1678138A1 Pyridine compounds as inhibitors of dipeptidyl peptidase iv
07/12/2006EP1677783A2 Fibrinogen receptor antagonists and their use
07/12/2006EP1677782A2 Inhibitors of cathepsin s
07/12/2006CN1802376A Cgrp受体拮抗剂 Cgrp receptor antagonists
07/12/2006CN1802370A Aroyl semicarbazide derivatives against thromboembolic diseases
07/12/2006CN1802369A Cgrp受体拮抗剂 Cgrp receptor antagonists
07/12/2006CN1802366A C-glycoside derivatives and salts thereof
07/12/2006CN1802360A 1,2,4-oxadiazole benzoic acid compounds
07/12/2006CN1802357A Aminopyrimidine derivatives and their medical use
07/12/2006CN1802350A Azetidinecarboxamide derivatives and their use in the treatment of CB1 receptor mediated disorders
07/12/2006CN1802187A Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
07/12/2006CN1802156A Aminoquinoline compounds
07/12/2006CN1263751C Novel compounds
07/12/2006CN1263748C A process for the preparation of bis-benzazolyl compounds
07/12/2006CN1263745C Aryl fused azapolycyclic compounds
07/11/2006US7074826 R-NSAID esters and their use
07/11/2006US7074821 Taxoids, their preparation and pharmaceutical composition containing them